Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
What dose and fractionation would you use to treat an AVM of the head and neck that is unable to undergo resection or embolization?
Related Questions
How do you counsel patients and partners of patients with HPV+ cancers regarding the HPV vaccine?
How do you approach patients with severe mucositis receiving chemo-radiation for head and neck cancer with regards to empiric antifungal or antiviral treatment?
What is your preferred radiation technique for treatment of skin cancer of the eyelid?
What would be your approach to the treatment of limited stage extrapulmonary small cell carcinoma of the nasopharynx with bilateral cervical lymphadenopathy?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
What approach do you take to determine dose constraints for SBRT reirradiation of the head and neck?
What is the significance of LVSI in determining post-op management for oropharyngeal cancer?
Are there special considerations when treating a patient with sarcomatoid SCC of the head and neck?
How would you manage pleomorphic adenoma of minor salivary glands involving hypopharynx/larynx with positive surgical margin?
What factors would prompt you to offer post-operative RT in early-stage (T1-2N0) nasal cavity squamous cell carcinoma?